SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-10-001399
Filing Date
2010-03-04
Accepted
2010-03-04 08:00:18
Documents
2
Period of Report
2010-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CELLDEX THERAPEUTICS, INC. 8-K a6201598.htm 8-K 16410
2 EXHIBIT 99.1 a6201598ex991.htm EX-99.1 75726
  Complete submission text file 0001157523-10-001399.txt   93844
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 10655508
SIC: 2835 In Vitro & In Vivo Diagnostic Substances